142 related articles for article (PubMed ID: 23055195)
21. Hypoxia-inducible factor 1 controls the expression of the uncoordinated-5-B receptor, but not of netrin-1, in first trimester human placenta.
Dakouane-Giudicelli M; Alfaidy N; Bayle P; Tassin de Nonneville A; Studer V; Rozenberg P; de Mazancourt P
Int J Dev Biol; 2011; 55(10-12):981-7. PubMed ID: 22252496
[TBL] [Abstract][Full Text] [Related]
22. Akt-phosphorylated PIKE-A inhibits UNC5B-induced apoptosis in cancer cell lines in a p53-dependent manner.
He K; Jang SW; Joshi J; Yoo MH; Ye K
Mol Biol Cell; 2011 Jun; 22(11):1943-54. PubMed ID: 21460185
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of S100C is associated with bladder cancer progression and poor survival.
Memon AA; Sorensen BS; Meldgaard P; Fokdal L; Thykjaer T; Nexo E
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):606-11. PubMed ID: 15701847
[TBL] [Abstract][Full Text] [Related]
24. Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.
Wang S; Xue S; Dai Y; Yang J; Chen Z; Fang X; Zhou W; Wu W; Li Q
Diagn Pathol; 2012 Nov; 7():159. PubMed ID: 23173870
[TBL] [Abstract][Full Text] [Related]
25. Correlation of ANXA1 expression with drug resistance and relapse in bladder cancer.
Yu S; Meng Q; Hu H; Zhang M
Int J Clin Exp Pathol; 2014; 7(9):5538-48. PubMed ID: 25337195
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
Tang K; Wang C; Chen Z; Xu H; Ye Z
Int J Clin Exp Pathol; 2015; 8(5):4999-5007. PubMed ID: 26191193
[TBL] [Abstract][Full Text] [Related]
27. Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence.
Huang P; Chen J; Wang L; Na Y; Kaku H; Ueki H; Sasaki K; Yamaguchi K; Zhang K; Saika T; Nasu Y; Watanabe M; Kumon H
Med Oncol; 2012 Jun; 29(2):829-34. PubMed ID: 21533858
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.
Ruan J; Wei B; Xu Z; Yang S; Zhou Y; Yu M; Liang J; Jin K; Huang X; Lu P; Cheng H
Med Oncol; 2013 Mar; 30(1):445. PubMed ID: 23307254
[TBL] [Abstract][Full Text] [Related]
29. Expression of beclin 1 in bladder cancer and its clinical significance.
Liu GH; Zhong Q; Ye YL; Wang HB; Hu LJ; Qin ZK; Zeng MS; Zeng BH
Int J Biol Markers; 2013 Apr; 28(1):56-62. PubMed ID: 23125008
[TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
[TBL] [Abstract][Full Text] [Related]
31. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.
Shen C; Wu Z; Wang Y; Gao S; Da L; Xie L; Qie Y; Tian D; Hu H
Cancer Med; 2020 Jun; 9(11):3885-3903. PubMed ID: 32250047
[TBL] [Abstract][Full Text] [Related]
32. D2-40/podoplanin expression in cancer stroma by immunohistochemical staining is associated with poor prognosis in bladder cancer patients after radical cystectomy.
Okajima E; Tomizawa M; Shimada K; Negishi T; Nishiyama N; Kitamura H
Urol Oncol; 2020 Oct; 38(10):797.e7-797.e13. PubMed ID: 32576528
[TBL] [Abstract][Full Text] [Related]
33. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
Hou S; Lin Q; Guan F; Lin C
J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
[TBL] [Abstract][Full Text] [Related]
34. Netrin-1 increases proliferation and migration of renal proximal tubular epithelial cells via the UNC5B receptor.
Wang W; Reeves WB; Ramesh G
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F723-9. PubMed ID: 19211685
[TBL] [Abstract][Full Text] [Related]
35. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
Xue Y; Wu G; Wang X; Zou X; Zhang G; Xiao R; Yuan Y; Long D; Yang J; Wu Y; Xu H; Liu F; Liu M
Med Oncol; 2013 Mar; 30(1):406. PubMed ID: 23275123
[TBL] [Abstract][Full Text] [Related]
36. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
[TBL] [Abstract][Full Text] [Related]
37. Expression of transcription factors snail, slug, and twist in human bladder carcinoma.
Yu Q; Zhang K; Wang X; Liu X; Zhang Z
J Exp Clin Cancer Res; 2010 Sep; 29(1):119. PubMed ID: 20809941
[TBL] [Abstract][Full Text] [Related]
38. Loss of DUSP2 predicts a poor prognosis in patients with bladder cancer.
Yin H; He W; Li Y; Xu N; Zhu X; Lin Y; Gou X
Hum Pathol; 2019 Mar; 85():152-161. PubMed ID: 30458195
[TBL] [Abstract][Full Text] [Related]
39. Non-muscle myosin II is an independent predictor of overall survival for cystectomy candidates with early-stage bladder cancer.
Xiong D; Ye YL; Chen MK; Qin ZK; Li MZ; Zhang H; Xu LH; Xu ZZ; Zeng MS
Oncol Rep; 2012 Nov; 28(5):1625-32. PubMed ID: 22895805
[TBL] [Abstract][Full Text] [Related]
40. Overexpression and clinicopathological contribution of DcR3 in bladder urothelial carcinoma tissues.
Jiang YQ; Zhong TF; Dang YW; Zou LS; Yang L; Yang X; Chen G
Asian Pac J Cancer Prev; 2014; 15(21):9137-42. PubMed ID: 25422191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
